| miRNA | gene name | experiments | ||||||
|---|---|---|---|---|---|---|---|---|
| hsa-miR-148b-5p | MCL1 |
|
||||||
| hsa-miR-148b-5p | PLS3 |
|
||||||
| hsa-miR-148b-5p | ACTL8 |
|
||||||
| hsa-miR-148b-5p | UBB |
|
||||||
| hsa-miR-148b-5p | AREL1 |
|
||||||
| hsa-miR-148b-5p | CISD3 |
|
||||||
| hsa-miR-148b-5p | NPTX2 |
|
||||||
| hsa-miR-148b-5p | TRNT1 |
|
||||||
| hsa-miR-148b-5p | PEG10 |
|
||||||
| hsa-miR-148b-5p | CYP1B1 |
|
||||||
| hsa-miR-148b-5p | BCL2L11 |
|
||||||
| hsa-miR-148b-5p | ATP5G3 |
|
||||||
| hsa-miR-148b-5p | ZNFX1 |
|
||||||
| hsa-miR-148b-5p | APC2 |
|
||||||
| hsa-miR-148b-5p | NPY4R |
|
||||||
| hsa-miR-148b-5p | KHSRP |
|
||||||
| hsa-miR-148b-5p | HIC2 |
|
||||||
| hsa-miR-148b-5p | CRIM1 |
|
||||||
| hsa-miR-148b-5p | BOC |
|
||||||
| hsa-miR-148b-5p | KIF23 |
|
||||||
| hsa-miR-148b-5p | TMEM117 |
|
||||||
| hsa-miR-148b-5p | ZNF264 |
|
||||||
| hsa-miR-148b-5p | FRAT2 |
|
||||||
| hsa-miR-148b-5p | SGO1 |
|
||||||
| hsa-miR-148b-5p | DUSP3 |
|
||||||
| hsa-miR-148b-5p | POLDIP2 |
|
||||||
| hsa-miR-148b-5p | ANP32E |
|
||||||
| hsa-miR-148b-5p | TRIB1 |
|
||||||
| hsa-miR-148b-5p | PCNX2 |
|
||||||
| hsa-miR-148b-5p | AQR |
|
||||||
| hsa-miR-148b-5p | YY2 |
|
||||||
| hsa-miR-148b-5p | ZNF592 |
|
||||||
| hsa-miR-148b-5p | ZNF175 |
|
||||||
| hsa-miR-148b-5p | PPP1R15A |
|
||||||
| hsa-miR-148b-5p | TRPM7 |
|
||||||
| hsa-miR-148b-5p | CCDC93 |
|
||||||
| hsa-miR-148b-5p | COL9A2 |
|
||||||
| hsa-miR-148b-5p | UBQLN1 |
|
||||||
| hsa-miR-148b-5p | PPP1R10 |
|
||||||
| hsa-miR-148b-5p | NSD1 |
|
||||||
| hsa-miR-148b-5p | SH3GLB1 |
|
||||||
| hsa-miR-148b-5p | ATRN |
|
||||||
| hsa-miR-148b-5p | MCM8 |
|
||||||
| hsa-miR-148b-5p | AIFM2 |
|
||||||
| hsa-miR-148b-5p | MSX2 |
|
||||||
| hsa-miR-148b-5p | SEC62 |
|
| authors | journal | year | Pubmed link | title | |
|---|---|---|---|---|---|
| 1 | Lam et al. | Mol. Cancer Ther. | 2010 | 20829195 | A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax). |
| 2 | Helwak et al. | Cell | 2013 | 23622248 | Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. |
| 3 | Karginov et al. | Genes Dev. | 2013 | 23824327 | Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. |
| 4 | Gottwein et al. | Cell Host Microbe | 2011 | 22100165 | Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. |
| 5 | Whisnant et al. | MBio | 2013 | 23592263 | In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. |
| 6 | Haecker et al. | PLoS Pathog. | 2012 | 22927820 | Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. |
| 7 | Xue et al. | Cell | 2013 | 23313552 | Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. |
| 8 | Farazi et al. | Genome Biol. | 2014 | 24398324 | Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets. |
| 9 | Memczak et al. | Nature | 2013 | 23446348 | Circular RNAs are a large class of animal RNAs with regulatory potency. |
| 10 | Hafner et al. | Cell | 2010 | 20371350 | Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. |
| 11 | Kishore et al. | Nat. Methods | 2011 | 21572407 | A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. |
| 12 | Lipchina et al. | Genes Dev. | 2011 | 22012620 | Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. |
| 13 | Skalsky et al. | PLoS Pathog. | 2012 | 22291592 | The viral and cellular microRNA targetome in lymphoblastoid cell lines. |
| 14 | Chi et al. | Nature | 2009 | 19536157 | Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. |